Cytokinetics Teams With Amgen
Cytokinetics Inc. (CYTK) teamed with Amgen Inc. (AMGN) to develop drugs for the treatment of heart failure. Shares of Cytokinetics surged $1.05 to $8.53 while Amgen stock added 97 cents to $69.28.
posted by FC Market News at 10:24 AM
1 Comments:
The record-breaking fundraising by several large buyout/growth equity funds (“mega-funds”) over the past couple of years has
led to heightened demand for people to help Los Angeles business
investorsthose funds. Specifically, the increased competitive pressures for top talent pushed compensation higher at the
mega-funds and had a trickle-down effect throughout the industry pushing compensation up at the mid- to larger-sized funds
which had to keep pace if they wanted to retain and attract top talent.
Post a Comment
<< Home